Cecropin A-like 4 (3-18)[K2W;G5,12W;K6W;E9W;Q13K;H14N;T15W]

General Information


DRACP ID  DRACP04133

Peptide Name   Cecropin A-like 4 (3-18)[K2W;G5,12W;K6W;E9W;Q13K;H14N;T15W]

Sequence  LWKIWWKIWRVWKNWR

Sequence Length  16

UniProt ID  A0A1I8M6I1 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C123H170N32O18

Absent amino acids  ACDEFGHMPQSTY

Common amino acids  W

Mass  265264

Pl  12.55

Basic residues  5

Acidic residues  0

Hydrophobic residues  10

Net charge  5

Boman Index  -2035

Hydrophobicity  -78.75

Aliphatic Index  91.25

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  33000

Absorbance 280nm  2200

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33401476

Title  Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17523

DRACP is developed by Dr.Zheng's team.